Literature DB >> 15673307

Activation of tubular epithelial cells by mesangial-derived TNF-alpha: glomerulotubular communication in IgA nephropathy.

Loretta Y Y Chan1, Joseph C K Leung, Anita W L Tsang, Sydney C W Tang, Kar Neng Lai.   

Abstract

BACKGROUND: IgA nephropathy (IgAN), characterized by mesangial IgA deposition, runs a variable clinical course with tubulointerstitial damage and renal failure in no less than 30% of patients. Histologically, IgA is rarely detected in renal tubules. The direct toxicity by IgA on renal tubules remains uncertain. We hypothesize that mediators released from human mesangial cells (HMC) triggered by IgA deposition may lead to activation of proximal tubular epithelial cells (PTEC).
METHODS: The binding of IgA to PTEC or HMC was assessed by flow cytometry. IgA-HMC medium was prepared by collecting the spent medium in which growth arrested HMC were incubated with IgA isolated from patients with IgAN, healthy control subjects, or other nephritic control patients. PTEC was cultured with the IgA-HMC medium in the presence or absence of neutralizing antibodies to TNF-alpha, IL-1beta, TGF-beta, or PDGF. Gene expression and protein synthesis of TNF-alpha, MIF, or ICAM-1 by PTEC were determined by RT-PCR and ELISA, respectively.
RESULTS: The binding of IgA isolated from patients with IgAN to PTEC was increased when compared to binding of IgA from healthy control subjects (P < 0.005). However, the binding to PTEC was less than one tenth that of HMC in IgAN. The binding to PTEC was not mediated through known IgA receptors, as shown by competitive binding assays and gene expression of the receptors. Despite the in vitro binding, PTEC cultured with isolated IgA exhibited no increased cell proliferation or enhanced synthesis of TNF-alpha, MIF, or sICAM-1. However, when PTEC were cultured with IgA-HMC medium prepared from IgAN patients, there was enhanced proliferation of PTEC (P < 0.001) and increased synthesis of TNF-alpha, MIF, and sICAM-1 when compared with PTEC cultured with IgA-HMC medium from control subjects (P < 0.001). The synthesis of MIF and sICAM-1 by PTEC cultured with IgA-HMC medium was reduced by neutralizing antibodies to TNF-alpha (P < 0.001) but not by neutralizing antibodies to IL-1beta, TGF-beta, or PDGF.
CONCLUSION: Our finding implicates that TNF-alpha released from the mesangium after IgA deposition activates renal tubular cells. The glomerulotubular communication could play an important role in the pathogenesis of tubulointerstitial damage in IgAN.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15673307     DOI: 10.1111/j.1523-1755.2005.67116.x

Source DB:  PubMed          Journal:  Kidney Int        ISSN: 0085-2538            Impact factor:   10.612


  31 in total

1.  Infliximab treatment in two patients with psoriatic arthritis and secondary IgA nephropathy.

Authors:  Grigorios T Sakellariou; Periklis Vounotrypidis; Charalampos Berberidis
Journal:  Clin Rheumatol       Date:  2006-08-19       Impact factor: 2.980

Review 2.  Available and incoming therapies for idiopathic focal and segmental glomerulosclerosis in adults.

Authors:  Mirco Belingheri; Gabriella Moroni; Piergiorgio Messa
Journal:  J Nephrol       Date:  2017-05-03       Impact factor: 3.902

Review 3.  Pathogenesis of IgA nephropathy.

Authors:  Kar Neng Lai
Journal:  Nat Rev Nephrol       Date:  2012-03-20       Impact factor: 28.314

Review 4.  New insights into the pathogenesis of IgA nephropathy.

Authors:  Jürgen Floege; Ivan C Moura; Mohamed R Daha
Journal:  Semin Immunopathol       Date:  2014-01-18       Impact factor: 9.623

5.  Crosstalk between TLR4 and Notch1 signaling in the IgA nephropathy during inflammatory response.

Authors:  Xuxiang Sheng; Xiaoyan Zuo; Xihui Liu; Yang Zhou; Xia Sun
Journal:  Int Urol Nephrol       Date:  2017-12-11       Impact factor: 2.370

6.  Effect of tonsillectomy with steroid pulse therapy on circulating tumor necrosis factor receptors 1 and 2 in IgA nephropathy.

Authors:  Maki Murakoshi; Tomohito Gohda; Yuji Sonoda; Hitoshi Suzuki; Yasuhiko Tomino; Satoshi Horikoshi; Yusuke Suzuki
Journal:  Clin Exp Nephrol       Date:  2017-04-07       Impact factor: 2.801

7.  Update on immunoglobulin A nephropathy, Part I: Pathophysiology.

Authors:  Maurizio Salvadori; Giuseppina Rosso
Journal:  World J Nephrol       Date:  2015-09-06

8.  Variants in Complement Factor H and Complement Factor H-Related Protein Genes, CFHR3 and CFHR1, Affect Complement Activation in IgA Nephropathy.

Authors:  Li Zhu; Ya-Ling Zhai; Feng-Mei Wang; Ping Hou; Ji-Cheng Lv; Da-Min Xu; Su-Fang Shi; Li-Jun Liu; Feng Yu; Ming-Hui Zhao; Jan Novak; Ali G Gharavi; Hong Zhang
Journal:  J Am Soc Nephrol       Date:  2014-09-09       Impact factor: 10.121

Review 9.  Chronic Inflammation in Chronic Kidney Disease Progression: Role of Nrf2.

Authors:  Peter Stenvinkel; Glenn M Chertow; Prasad Devarajan; Adeera Levin; Sharon P Andreoli; Sripal Bangalore; Bradley A Warady
Journal:  Kidney Int Rep       Date:  2021-05-04

10.  Increased plasma sVCAM-1 is associated with severity in IgA nephropathy.

Authors:  Li Zhu; Sufang Shi; Lijun Liu; Jicheng Lv; Hong Zhang
Journal:  BMC Nephrol       Date:  2013-01-22       Impact factor: 2.388

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.